Clinical Trials Browser

Anatomic Stage I Breast Cancer AJCC v8 × trastuzumab biosimilar HLX02 × 90 days × Clear all

NCT07407920 2026-02-12

Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial

Phase 2 Active not recruiting

Anatomic Stage I Breast Cancer AJCC v8